<DOC>
	<DOCNO>NCT02852876</DOCNO>
	<brief_summary>The objective study evaluate safety tolerability single rising dos ASP2151 fast condition healthy male subject . The study also evaluate pharmacokinetics ( PK ) single dose ASP2151 fast versus feed condition healthy male subject .</brief_summary>
	<brief_title>Study Evaluate Safety Pharmacokinetics Single Doses ASP2151 Healthy Male Subjects Effects Food</brief_title>
	<detailed_description>Study divide two part . Part 1 evaluate safety tolerability ASP2151 single rising dos group A-H fast condition determine maximum tolerable dose ( MTD ) possible . Part 2 evaluate effect fast versus fed condition safety , tolerability PK single dose ASP2151 two treatment cycle . The wash-out period two treatment cycle least 5 day shorter five time average elimination half-life ASP2151 , determine part 1 study .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Herpes Genitalis</mesh_term>
	<criteria>Body weight 60 100 kg , BMI 18 30 kg/m2 inclusive Known suspect hypersensitivity ASP2151 component formulation use Any clinically significant history asthma , eczema , allergic condition previous severe hypersensitivity drug Any clinically significant history genital herpes symptom and/or herpes zoster symptom 3 month prior admission Clinical Unit Any clinically significant history disease disorder gastrointestinal , cardiovascular , respiratory , renal , hepatic , neurological , dermatological , psychiatric metabolic Abnormal pulse rate and/or blood pressure measurement prestudy visit follow : Pulse rate &lt; 40 &gt; 90 bpm ( beat per minute ) ; mean systolic blood pressure &lt; 90 &gt; 140 mmHg ( millimeter mercury ) ; mean diastolic blood pressure &lt; 40 &gt; 95 mmHg Regular use prescribe OTC ( counter ) drug 4 week prior admission Clinical Unit OR use drug 2 week prior admission Clinical Unit Any use drug abuse within 3 month prior admission Clinical Unit History smoke 10 cigarette per day within 3 month prior admission Clinical Unit History drink 21 unit alcohol per week within 3 month prior admission Clinical Unit Donation blood blood product within 3 month , prior admission Clinical Unit Positive serology test HBsAg ( Hepatitis B surface antigen ) , HAV IgM ( Hepatitis A Virus ) , antiHCV ( Hepatitis C Virus ) antiHIV ( Human Immunodeficiency Virus ) 1 2 Not willing able swallow size 00 capsule</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Safety ASP2151</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy male subject</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Food effect ASP2151</keyword>
</DOC>